Page last updated: 2024-09-05

sorafenib and Renal Artery Stenosis

sorafenib has been researched along with Renal Artery Stenosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Busaidy, NL; Habra, MA; Schellingerhout, D; Shawa, H1

Other Studies

1 other study(ies) available for sorafenib and Renal Artery Stenosis

ArticleYear
Unilateral renal artery stenosis with renal atrophy in a patient with metastatic papillary thyroid carcinoma treated with sorafenib.
    BMJ case reports, 2013, May-15, Volume: 2013

    Topics: Antineoplastic Agents; Atrophy; Carcinoma; Carcinoma, Papillary; Female; Humans; Kidney; Middle Aged; Niacinamide; Phenylurea Compounds; Renal Artery Obstruction; Sorafenib; Thyroid Cancer, Papillary; Thyroid Neoplasms

2013